Section 25.5-5-513 - Pharmacy benefits - prescription drugs - rebates - analysis(1) Beginning in 2023, the state department shall, in collaboration with the administrator of the all-payer health claims database described in section 25.5-1-204, conduct an annual analysis of the prescription drug rebates received in the previous calendar year, by health insurance carrier and prescription drug tier. The analysis, using data from the all-payer health claims database and other sources, must be completed on or before May 1 of each year.(2) The state department shall make the analysis conducted in subsection (1) of this section available to the public on an annual basis.Added by 2022 Ch. 184, § 7, eff. 8/10/2022. 2022 Ch. 184, was passed without a safety clause. See Colo. Const. art. V, § 1(3).